Literature DB >> 11786580

When the treatment goal is not cure: are cancer patients equipped to make informed decisions?

Melina Gattellari1, Katie J Voigt, Phyllis N Butow, Martin H N Tattersall.   

Abstract

PURPOSE: Informed decision making now is considered the underpinning of ethical medical practice. We aimed to determine the extent to which patients with incurable cancer are adequately informed of their prognosis and treatment options and encouraged to participate in treatment decisions. PATIENTS AND METHODS: One hundred eighteen cancer patients with incurable disease presenting for an initial consultation with one of nine oncologists at two Sydney tertiary referral hospitals participated in the study. Consultations were recorded on audiotape to permit a content analysis of doctor-patient interactions. We devised a coding system to assess disclosure of information and to evaluate doctor encouragement of patient participation in treatment decision making. Patient recall, satisfaction, anxiety, and perceptions of the decision-making process were assessed to determine the effects of informed decision making on patient outcomes.
RESULTS: Most patients were informed about the aim of anticancer treatment (84.7%), that their disease was incurable (74.6%), and about life expectancy (57.6%). An alternative to anticancer treatments was presented to 44.1%, 36.4% were informed about how anticancer treatment would affect quality of life, and 29.7% were offered a management choice. Oncologists checked patient understanding in only 10.2% of consultations. Although greater information disclosure did not seem to elevate anxiety levels, greater patient participation in the decision-making process was associated with increased anxiety levels (P =.0005), which persisted over a 2-week time span.
CONCLUSION: Most patients were well informed, but important gaps remain, especially concerning information about prognosis and alternatives to anticancer treatment. These gaps invite the question concerning whether patients are led toward anticancer treatment.

Entities:  

Keywords:  Empirical Approach; Professional Patient Relationship

Mesh:

Year:  2002        PMID: 11786580     DOI: 10.1200/JCO.2002.20.2.503

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  75 in total

Review 1.  Communication and informed consent in phase 1 trials: a review of the literature.

Authors:  A C Cox; L J Fallowfield; V A Jenkins
Journal:  Support Care Cancer       Date:  2006-01-28       Impact factor: 3.603

Review 2.  Informed consent for clinical treatment.

Authors:  Daniel E Hall; Allan V Prochazka; Aaron S Fink
Journal:  CMAJ       Date:  2012-03-05       Impact factor: 8.262

Review 3.  Reluctance to disclose difficult diagnoses: a narrative review comparing communication by psychiatrists and oncologists.

Authors:  Alex J Mitchell
Journal:  Support Care Cancer       Date:  2007-07       Impact factor: 3.603

4.  Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial.

Authors:  Inge Henselmans; Hanneke W M van Laarhoven; Hanneke C J M de Haes; Meltem Tokat; Ellen G Engelhardt; Pomme E A van Maarschalkerweerd; Marleen Kunneman; Petronella B Ottevanger; Serge E Dohmen; Geert-Jan Creemers; Dirkje W Sommeijer; Filip Y F L de Vos; Ellen M A Smets
Journal:  Oncologist       Date:  2018-06-29

5.  Effect of advanced cancer patients' awareness of disease status on treatment decisional conflicts and satisfaction during palliative chemotherapy: a Korean prospective cohort study.

Authors:  Sun Kyung Baek; Si-young Kim; Dae Seog Heo; Young Ho Yun; Myung Kyung Lee
Journal:  Support Care Cancer       Date:  2011-07-01       Impact factor: 3.603

Review 6.  A systematic review of communication quality improvement interventions for patients with advanced and serious illness.

Authors:  Oluwakemi A Fawole; Sydney M Dy; Renee F Wilson; Brandyn D Lau; Kathryn A Martinez; Colleen C Apostol; Daniela Vollenweider; Eric B Bass; Rebecca A Aslakson
Journal:  J Gen Intern Med       Date:  2012-10-26       Impact factor: 5.128

7.  Patients' expectations about effects of chemotherapy for advanced cancer.

Authors:  Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

8.  Development and evaluation of a decision aid for patients considering first-line chemotherapy for metastatic breast cancer.

Authors:  Kimberly S Chiew; Heather Shepherd; Janette Vardy; Martin H N Tattersall; Phyllis N Butow; Natasha B Leighl
Journal:  Health Expect       Date:  2008-03       Impact factor: 3.377

9.  Resident preparedness in discussing prognosis in patients with advanced lung cancer.

Authors:  Paul Wheatley-Price; Christine Massey; Tony Panzarella; Frances A Shepherd; Joseph Mikhael
Journal:  Support Care Cancer       Date:  2009-07-21       Impact factor: 3.603

10.  Using patient and physician perspectives to develop a shared decision-making framework for colorectal cancer.

Authors:  Marisa Leon-Carlyle; Gillian Spiegle; Selina Schmocker; Anna Gagliardi; David Urbach; Erin Kennedy
Journal:  Implement Sci       Date:  2009-12-24       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.